Amazon’s $11.6 Billion Globalstar Grab Is About More Than Satellites — It’s a Direct Challenge to Starlink’s Dominance

Amazon’s acquisition of Globalstar for approximately $11.57 billion — or $90 per share — is one of the most strategically loaded deals of 2026, and it’s a reminder that small-cap companies can sit at the center of the biggest transactions in the market. Globalstar, once a modest satellite operator with a market cap well beneath the radar of most institutional investors, has become the cornerstone of Amazon’s bid to compete directly with Elon Musk’s SpaceX in the rapidly expanding space connectivity market — while simultaneously locking in a critical partnership with Apple.

The Strategic Play

Amazon has been building its satellite internet business — rebranded from Project Kuiper to Leo — for years, but the company has faced significant headwinds. It currently has roughly 240 satellites in orbit compared to Starlink’s fleet of more than 10,000, and it recently had to ask the FCC for an extension on a requirement to deploy approximately 1,600 satellites by July 2026. Acquiring Globalstar addresses a key structural gap: direct-to-device capability.

Globalstar operates around 24 satellites and holds spectrum licenses with global authorizations — assets that are notoriously difficult and time-consuming to obtain independently. Rather than build this foundation from scratch, Amazon is buying it. The company plans to start deploying its own direct-to-device satellite system using these assets by 2028.

The Apple Dimension

Apple’s fingerprints are all over this deal. The iPhone maker took a 20% stake in Globalstar in 2024 through a $1.5 billion investment, primarily to power its Emergency SOS satellite feature. As part of the Amazon acquisition, a separate agreement was struck for Amazon to provide satellite connectivity for current and future iPhones and Apple Watch features — a significant commercial arrangement that effectively makes Amazon a behind-the-scenes infrastructure provider for Apple’s device ecosystem.

This isn’t a minor footnote. It signals that Amazon is positioning Leo not just as a consumer internet service competing with Starlink, but as a B2B infrastructure layer for some of the world’s most widely used consumer devices.

Regulatory Outlook

FCC Chairman Brendan Carr acknowledged the acquisition on Tuesday, describing the agency as open-minded to the deal and noting its potential to create a viable U.S. competitor to SpaceX in direct-to-cell services. The transaction is expected to close in 2027, leaving meaningful time for regulatory review.

Carr’s framing is notable — the FCC has been consistent in its messaging that it wants to encourage competition in the satellite broadband market, not constrain it. Amazon had ironically opposed a SpaceX application before the FCC last month, so the agency’s receptiveness to this deal will be worth monitoring.

What This Means for the Market

Globalstar shareholders will receive either $90 in cash or 0.3210 shares of Amazon common stock per Globalstar share — a structure that reflects Amazon’s confidence in its own equity. For investors watching the satellite and space economy, this deal narrows the competitive field considerably. The race to own low-Earth orbit spectrum and direct-to-device infrastructure is intensifying, and scale is the only real moat.

Amazon just bought itself a meaningful head start. Whether it’s enough to close the gap with Starlink remains the central question for the next decade of space-based connectivity

Snail (SNAL) – Licensing Agreement Raises Cash Flow; Raise Price Target


Tuesday, April 14, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Snail Renegotiates ARK License. The amendment lowers fixed licensing costs from $2.0 million to $1.5 million per month, implying  $1.5 million in quarterly savings. The obligation remains in place until the release of ARK 2, preserving near-term cost visibility. The move shows that the company is independently evaluating contracts on a timely basis.

DLC Payment Terms Revised to Reduce Future Cash Obligations. The amendment replaces blanket $5 million DLC payments with a more selective structure, excluding certain content such as DLCs already bundled in ARK: Survival Ascended. This change further moderates future cash outflows tied to the franchise. Improved cash flow generation provides greater flexibility to invest in upcoming titles and franchise development. It also reduces financial risk as the company transitions toward the next major ARK release.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

The Oncology Institute, Inc. (TOI) – CMS Model Shows Medicare Cost Savings, Supporting Our Investment Thesis


Tuesday, April 14, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

TOI Methodology Continues To Improve Medicare Cost Savings. TOI announced new data from the Enhancing Oncology Model (EOM) developed by the Centers for Medicare & Medicaid Services (CMS). Data from CMS shows that during Performance Period 3, the six-month period beginning July 2024, TOI achieved cost savings of $1.8 million, equating to $6,400 per patient-episode. This compares with the Performance Period 2, from January 2024 to June 2024, in which savings were $1.1 million or $3,500 per episode.

TOI Methodology Fits Well With The EOM. The CMS Innovation Center developed the EOM as a total-cost-of-care model to improve cancer care for Medicare Fee-for-Service beneficiaries. It incentivizes oncology practices to deliver coordinated care for patients receiving chemotherapy. The EOM model has identified pharmacy, avoidable acute care, and supportive care as the three main areas for cost reduction and quality-of-care improvements. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

First Phosphate Corp. (FRSPF) – First Phosphate Achieves Another Major Milestone


Tuesday, April 14, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Advancing financing efforts with international support. First Phosphate has secured a letter of interest (LOI) from the Export and Investment Fund of Denmark (EIFO) for up to €170 million to support equipment and service purchases for its Begin-Lamarche igneous phosphate project in Saguenay–Lac-Saint-Jean, Quebec. EIFO, owned and backed by the Danish government and effectively AAA-rated, would provide a guarantee to participating banks, with its involvement expected to be pro rata and pari passu alongside other senior lenders.

Global experience in export and project finance. EIFO brings extensive global experience in export and project finance, having supported numerous international transactions. The proposed guarantee remains subject to EIFO’s internal credit approvals and completion of project due diligence. The LOI is non-binding pending finalization of borrower, guarantor, and security arrangements, and will be governed by Danish law.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Obsidian Therapeutics Goes Public Through Galera Merger, Lands $350 Million to Fuel Cell Therapy Pipeline

A microcap biotech is getting a new identity — and $350 million to go with it.

Galera Therapeutics (OTC: GRTX) and privately-held Obsidian Therapeutics announced today they have entered into a definitive merger agreement to combine in an all-stock transaction. The combined company will operate as Obsidian Therapeutics and plans to trade on Nasdaq under the ticker symbol OBX.

For Galera shareholders, this is a lifeline. The stock was trading at less than five cents on the OTC markets heading into this announcement. For Obsidian, it’s a calculated path to the public markets — using Galera as a vehicle to access Nasdaq without a traditional IPO.

The Deal Structure

Under the merger agreement, Galera will merge into a subsidiary of the new parent company, Gazelle Parent, Inc., while Obsidian simultaneously merges into a separate subsidiary — with both surviving as wholly owned subsidiaries of the combined parent.

Concurrent with the merger, the companies secured commitments for a private placement financing expected to generate $350 million in gross proceeds. That’s a substantial war chest for a clinical-stage biotech, and signals serious institutional conviction in Obsidian’s pipeline.

The ownership breakdown tells the real story of who’s driving this combination: pre-merger equityholders of Obsidian are expected to own approximately 53.2% of the combined company, PIPE investors approximately 45%, and Galera’s legacy shareholders approximately 1.8%. Galera’s existing stockholders are essentially getting a small equity stake in a well-funded new entity rather than facing dissolution.

Who’s Backing It

Investors in the private placement include Balyasny Asset Management, Caligan Partners, Eventide Asset Management, Nantahala Capital, Octagon Capital, Redmile, Spruce Street Capital, and Trails Edge Capital Partners. That’s a roster of credible, healthcare-focused institutional names — not speculative money.

What Obsidian Actually Does

Obsidian focuses on engineered cell and gene therapies targeting unmet medical needs, while Galera had concentrated on treatments for radiation-induced toxicities. The combined company’s primary asset is OBX-115, a TIL (tumor-infiltrating lymphocyte) cell therapy. The company expects Phase 1 NSCLC data in the first half of 2027 and topline data from a melanoma registration-enabling trial by year-end 2027, supported by the merged company’s expanded cash runway.

TIL cell therapy is an emerging but compelling approach in oncology — it extracts a patient’s own immune cells from a tumor, engineers them, and reinfuses them to fight cancer. The space has attracted significant Big Pharma attention as cell therapy continues to mature beyond CAR-T into broader tumor types.

The Bigger Picture

This transaction is a textbook example of a structure the small-cap biotech world relies on — a reverse merger into a public shell paired with a concurrent PIPE to fund the surviving entity’s operations. It avoids the cost and volatility of a traditional IPO while still achieving a Nasdaq listing and fresh capital.

Closing requires approval from Galera and Obsidian stockholders, effectiveness of a Form S-4 registration statement, receipt of the approximately $350 million in private placement proceeds, and Nasdaq approval for the new parent’s listing.

For small-cap investors, the question now is whether OBX can justify that institutional confidence when the clinical data arrives in 2027.

Oracle’s 10% Surge Is a Signal, Not Just a Stock Move — Here’s What Investors Should Watch

Oracle (NYSE: ORCL) is one of the few names flashing green in a market defined by red this Monday. While the Dow shed hundreds of points on the news of a U.S. naval blockade of the Strait of Hormuz, Oracle surged roughly 10% — moving from deeply oversold territory toward $153 a share on volume running well above its daily average. The catalyst is a combination of new AI product launches, a fresh cloud infrastructure expansion, and a broader rotation back into beaten-down enterprise software names. For small and microcap investors watching from the sidelines, the move carries a message worth decoding.

The immediate triggers are concrete. Oracle rolled out AI-powered upgrades to its Utilities Industry Suite and Aconex project management platform today, targeting utility operators looking to cut costs and improve grid reliability. The company also launched a new public cloud region in Casablanca, Morocco — the latest milestone in an aggressive global infrastructure buildout that has pushed its capital expenditure to levels unseen in the company’s history. Underlying all of it is a backlog that has grown 325% year over year, reaching $553 billion in committed future business as of Oracle’s most recent quarter. Revenue in Q3 fiscal 2026 rose 22% year over year, with cloud revenue up 44%.

What makes today’s rally notable is its context. Oracle is still down roughly 54% from its 52-week high of $345.72 set last September. The stock has been punished by investor skepticism around its aggressive AI infrastructure spending, rising debt levels, and a recent round of layoffs across its SaaS and NetSuite divisions. Today’s move suggests that at current valuations, the market is beginning to reassess whether the selloff overshot — particularly as renewed momentum around large-scale AI infrastructure deals involving OpenAI, Meta, and Anthropic reinforces demand signals for the cloud and compute buildout Oracle is betting on.

That reassessment matters beyond Oracle itself. The AI infrastructure trade has been one of the most crowded and most brutalized in the market over the past several months. Large-cap names absorbed the most visible damage, but smaller cloud-adjacent and AI infrastructure companies have been hit just as hard, often harder, with far less coverage and liquidity to cushion the fall. When sentiment begins to shift at the top of the market cap spectrum, it historically filters down — and the small and microcap companies building the picks-and-shovels layer of the AI stack are typically the last to recover, and sometimes the most dramatically when they do.

The risk to that thesis is execution. Oracle’s rally today is a sentiment-driven repricing, not a fundamental re-rating. A company carrying Oracle’s level of capital expenditure and debt in a $100-plus oil environment faces real cost pressures that don’t disappear because a stock bounces 10% in a session. The AI infrastructure buildout remains a long-duration bet, and the geopolitical backdrop continues to add inflation risk that could delay the rate relief many levered tech companies are counting on.

But the signal embedded in today’s move is worth taking seriously. When a company sitting on over half a trillion dollars in committed backlog starts getting bought aggressively on a down-market day, the market is telling you something about where conviction is quietly returning — and in AI infrastructure, that conviction tends to travel down the size spectrum faster than most expect.

The Domestic Small-Cap Energy Story the Market Is Just Starting to Price In

West Texas Intermediate crossed $104 per barrel Monday morning as the U.S. formally blockaded the Strait of Hormuz, putting an official military stamp on a crisis that has already cut the waterway’s commercial traffic by more than 90% since late February. Oil has surged more than 55% since the U.S.-Israel air campaign against Iran began. The large-cap conversation around this move centers on inflation, rate policy, and Big Oil earnings. The small-cap opportunity underneath it is considerably more specific — and considerably less crowded.

Domestic energy producers don’t carry the insurance exposure, rerouting costs, or geopolitical risk that’s hammering international supply chains. When global energy flows are disrupted at the source — and the Strait of Hormuz handles roughly 25% of the world’s seaborne oil and 20% of global LNG exports — the demand vacuum gets filled by producers operating entirely outside the conflict zone. U.S. domestic natural gas producers, onshore oil operators, and domestic refiners are each collecting a demand premium that didn’t exist eight weeks ago.

The LNG dynamic is particularly important for small-cap energy investors. Qatar and the UAE supply a substantial share of LNG to Asian buyers. With Qatari LNG facilities struck by Iranian drones and Gulf shipping lanes effectively closed, Asian markets are competing aggressively for alternative supply — pulling from U.S. export terminals at a pace that is tightening the domestic natural gas market. That demand surge is landing at exactly the moment AI infrastructure is driving electricity consumption higher. Data centers require massive volumes of consistent baseload power, and natural gas remains the backbone of that grid in the United States. The theoretical “AI-Energy Nexus” that analysts have been discussing is no longer theoretical — it is being forced into reality by a geopolitical event that knocked out the world’s primary LNG export corridor.

Domestic refiners are in a comparably favorable position. With crude prices elevated and refining margins widening as global capacity strains, mid-size operators processing domestic crude are capturing spread that simply wasn’t available in a $70-per-barrel world. Large-cap refining names have already moved. Many small and microcap upstream producers with pure domestic production profiles have lagged the repricing — a pattern that historically corrects as the supply story matures and investors rotate down the market cap spectrum.

The broader implications extend beyond hydrocarbons. The Hormuz crisis is accelerating a policy conversation with real capital allocation consequences: the shift from “green energy” to “secure energy.” Nuclear, domestic grid hardening, and U.S.-based energy infrastructure are being reconsidered as national security imperatives rather than purely climate investments. That reframing is attracting new institutional attention to sectors that were previously viewed as transitional.

The primary risk is speed. A diplomatic breakthrough or a durable ceasefire could reverse oil toward the $80 range and compress margins that have only recently expanded. Energy executives are warning, however, that even if the Strait reopens, infrastructure damage and the global shipping backlog could take months to fully unwind — putting a floor under the repricing that has already occurred.

For investors focused on the small and microcap space, the Hormuz crisis is not just an oil price story. It is a structural demand signal for domestic producers operating in a global market that suddenly cannot source enough of what they have.

Vince Holding Corp. (VNCE) – Margins Trending Towards the High End of Guidance


Friday, April 10, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Solid holiday performance. For the nine-week period ended January 3, 2026, total company net sales increased 5.3% year over year, supported primarily by steady demand and continued strength in the Direct-to-Consumer segment. Furthermore, management attributed the improvement to ongoing investments in customer experience, digital capabilities, and omnichannel engagement.

DTC leads the way. Notably, Direct-to-Consumer revenue increased 9.7% versus the prior-year holiday period, underscoring strong traffic conversion across e-commerce and retail locations. In contrast, the Wholesale segment declined 2.7% year over year, reflecting disruption in receipt flow related to its partner Saks Global. Despite this pressure, management indicated that strong point-of-sale performance with key partners partially offset the disruption.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Resolution Minerals Ltd (RLMLF) – Antimony Ridge Takes a Big Step Forward


Friday, April 10, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Fast-41 Designation. Resolution Minerals Ltd (OTCQB: RLMLF, ASX: RML) is advancing its Antimony Ridge Project in Idaho as a strategically significant source of antimony within the United States, reinforced by its recent inclusion in the Federal FAST 41 Permitting Transparency Program. This designation underscores the project’s importance to national security and critical mineral supply chains while supporting accelerated permitting, enhanced regulatory coordination, and increased visibility with investors and strategic partners.

Large-Scale Potential. The project demonstrates strong large-scale potential, with recent modeling defining an extensive and expanding mineralized system hosting high grade antimony and silver across a substantial footprint. Historical production and recent sampling confirm exceptionally high grades, while mineralization remains open in multiple directions, indicating considerable upside and resource growth potential.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Resources Connection (RGP) – 3Q26 Results In-Line, But End Markets Remain Challenging


Friday, April 10, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. For the third quarter of fiscal 2026, Resources Connection produced results that were aligned with management’s previous guidance for revenue and gross margin, while run-rate SG&A expenses were better than the outlook. During the quarter, management continued to strengthen leadership, meaningfully reduced the cost structure, took steps to simplify the business portfolio, and began reinvesting selectively to support future growth.

3Q26 Results. Revenue in 3Q26 was $107.9 million compared to $129.4 million in 3Q25. We were at $108 million. On a same-day constant currency basis, revenue decreased by $25.4 million, or 19.6%. Billable hours decreased 16.3% year-over-year, and the Company average bill rate for 3Q26 decreased 1.0% year-over-year, or 2.1% on a constant currency basis. RGP reported a GAAP net loss of $9.5 million, or a loss of $0.28/sh. Adjusted net loss was $0.09/sh. We were at a loss of $0.31/sh and $0.08/sh, respectively.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Four Quarters and Counting: Why Small Caps Keep Winning While Mega Caps Stumble

The numbers are in, and small and microcap stocks did something in Q1 2026 that barely anyone predicted going into the year — they survived.

That may sound like a low bar, but context matters. The first quarter was anything but quiet. Global equity markets started 2026 on solid footing before the U.S.-Israel conflict with Iran rattled investor confidence, shut down the Strait of Hormuz, and sent energy prices surging past $110 a barrel. Sticky inflation, elevated unemployment, tariff uncertainty, and fears of a broader market correction were already in the backdrop. Against all of that, the Russell 2000 gained 0.9% and the Russell Microcap advanced 1.5% in Q1 2026.

Meanwhile, the large-cap Russell 1000 declined 4.2% while the mega-cap Russell Top 50 fell 7.9% — what one firm has aptly called the “Mag 7” becoming the “Lag 7.”

This marks the fourth consecutive quarter in which the microcap index beat the major domestic large-cap indexes — a streak that’s becoming harder to dismiss as a blip. The 12-month spread between the small and microcap indexes and their large-cap counterparts is now the fourth widest since the Russell Microcap’s inception in 2000.

The one-year numbers drive the point home even further. For the period ended March 31, 2026, the Russell Microcap gained 45.8%, the Russell 2000 advanced 25.7%, the Russell 1000 rose 17.7%, and the Russell Top 50 increased 19.5%.

What’s fueling the durability? Several forces are working simultaneously in favor of smaller companies. The Federal Reserve’s rate-cutting cycle, which delivered 175 basis points of cuts, has been particularly potent for smaller companies — nearly 40% of Russell 2000 constituents carry floating-rate debt, meaning rate relief hits their bottom lines directly and immediately. The reshoring movement continues to channel investment toward domestically focused manufacturers and industrial suppliers — the exact profile of the average small cap company. And the One Big Beautiful Bill Act’s provisions on bonus depreciation and R&D expensing have given capital-intensive smaller companies a meaningful cash flow lift.

Sector performance within small caps told its own story. Energy, Industrials, and Materials made the biggest positive contributions in Q1, while Health Care, Information Technology, and Consumer Discretionary were the primary detractors. At the industry level, oil, gas and consumable fuels, energy equipment and services, and electrical equipment led gains. The Iran conflict, while painful for the broader market, actually became a tailwind for small-cap energy names — a sector that entered the year already cheap and underleveraged.

The valuation case remains compelling. Even with the most recent outperformance, the Russell 2000 remains extremely undervalued compared to its relative valuation range over the past 25 years. Royce

For investors still waiting on the sidelines for “better conditions” to rotate into small and microcap names, Q1 2026 delivered another uncomfortable data point: the rotation is already happening, and it’s already in its fourth consecutive quarter of confirmation.

The Magnificent Seven had a long, good run. The market appears to be moving on.

CoreWeave’s 13% Surge Reveals Who’s Really Winning the AI Infrastructure Race

The AI chip arms race just found its latest winner — and it’s not a semiconductor company.

CoreWeave (CRWV) shares surged more than 13% on Friday after the AI cloud infrastructure company announced a multiyear agreement with Anthropic, the AI safety company behind the Claude family of models. The deal will have CoreWeave providing computing capacity to run Anthropic’s workloads at production scale, with an initial phased rollout and room to expand. Financial terms, including pricing and chip capacity, were not disclosed.

The market’s reaction is telling. In an environment where AI companies are racing to lock down computing resources, the companies sitting in between the chip makers and the model builders — the infrastructure layer — are emerging as some of the most strategically valuable players in the ecosystem.

The Infrastructure Bottleneck Is Becoming a Competitive Moat

The CoreWeave-Anthropic deal doesn’t exist in a vacuum. It’s one piece of a rapidly consolidating AI infrastructure picture. Earlier this week, Anthropic separately announced it is working with Broadcom (AVGO) and Google to access 3.5 gigawatts of Google’s Broadcom-built Tensor Processing Units. Reports have also surfaced that Anthropic is exploring designing its own custom semiconductors — a move that would put it in the same category as OpenAI, Meta, Amazon, and Google, all of which are building or already operating proprietary chip programs.

What this signals is that the dependency on Nvidia (NVDA), while still very real, is being hedged at every level of the AI stack. Companies are pursuing multiple supply channels simultaneously — third-party cloud infrastructure like CoreWeave, hyperscaler partnerships, and in-house silicon development — because a single point of failure in computing capacity is existential risk for an AI business.

CoreWeave Is Becoming the Go-To AI Cloud

What makes CoreWeave’s position particularly interesting is how quickly it has become the preferred infrastructure partner for frontier AI labs. Meta (META) signed a deal with CoreWeave that runs through December 2032, giving the social media giant a long-term runway for powering its AI services. Now Anthropic joins that roster.

CoreWeave also noted that its capacity for Anthropic’s workloads will be distributed across multiple data center locations and will include some of the first commercial deployments of Nvidia’s next-generation Vera Rubin architecture — a detail that adds both technical credibility and scarcity value to the agreement.

Why This Matters Beyond the Stock Move

For investors and market watchers focused on the AI infrastructure theme, CoreWeave’s deal flow tells a clear story: the companies building and maintaining the physical layer of AI — the data centers, the networking, the GPU clusters — are becoming critical infrastructure in the truest sense of the term. The demand is not slowing, and the supply is constrained enough that long-term agreements are being inked across the board.

The winners in this cycle may not be the most visible AI brands. They may be the ones quietly building the backbone everyone else depends on.

CoreWeave is shaping up to be exactly that.

Burry vs. Palantir: Is the AI Era Exposing a Crack in the Foundation?

Michael Burry has built a career on being early — and loudly wrong before being right. The founder of Scion Asset Management, immortalized for his prescient bet against the U.S. housing market ahead of the 2008 financial crisis, turned his sights on Palantir Technologies (PLTR) this week with a pointed post on X that sent the stock tumbling roughly 7% before he quietly deleted it.

The claim was simple and blunt, as Burry tends to be: Anthropic, the AI startup behind the Claude platform, is “eating Palantir’s lunch.”

Whether he’s right is a separate question. What’s not debatable is that the market paid attention.

What Burry Actually Said

Burry’s thesis centered on Anthropic’s explosive revenue growth — from $9 billion to $30 billion in annual recurring revenue (ARR) in a matter of months — as evidence that enterprise customers are gravitating toward AI solutions that are “easier, cheaper, and more intuitive.” His argument frames Palantir less as a high-growth technology company and more as a labor-intensive consulting business, pointing to the company’s reliance on Forward Deployed Engineers (FDEs) — Palantir staff embedded inside client organizations for months at a time to implement and maintain its platforms.

That model, Burry argued, is structurally vulnerable as direct AI integrations become more accessible. “It took $PLTR 20 years to get to $5 billion,” he noted, while Anthropic is scaling at a pace that suggests the market may be ready to reward the brains of the AI revolution over the operating systems built around it.

This isn’t a new position for Burry. He disclosed a significant short position in Palantir via long-dated put options as far back as September 2025.

The Bull Case: Palantir’s Moat is Real

Not everyone on Wall Street is ready to write Palantir’s eulogy. Wedbush analyst Dan Ives maintains an Outperform rating with a $230 price target, arguing that Palantir occupies a uniquely defensible position at the intersection of AI and federal government infrastructure. The argument: you cannot run sophisticated AI on sensitive government data without the kind of secure, structured, and compliant data architecture that Palantir provides.

That argument gained added texture this year when the Trump administration banned Anthropic from Pentagon systems following a dispute over AI safety guardrails. Palantir was reportedly ordered to remove Claude from its Maven Smart System and rebuild parts of the platform. That incident, while disruptive in the short-term, arguably underscores the stickiness of Palantir’s enterprise relationships — and the risk that pure AI model providers face in regulated environments where trust, compliance, and security clearances matter as much as raw capability.

Palantir has also posted ten consecutive quarters of accelerating revenue growth, a track record that speaks for itself regardless of how the competitive landscape evolves.

The Bear Case: Valuation Leaves Little Room for Error

Where the bull case gets complicated is on valuation. Morgan Stanley analyst Sanjit Singh, while acknowledging Palantir’s standing as a “clear winner through the first stage of the AI cycle,” has flagged that the stock currently trades at roughly 38 times 2027 sales. At that multiple, even strong execution may not be enough to drive meaningful upside. The bar is simply very high.

Burry’s consulting-business critique also has some factual grounding. Palantir’s 10-K does categorize its FDE deployments under professional services — a labor-driven revenue model that is inherently harder to scale than a software subscription or API-based product. As Anthropic and similar companies lower the barrier to deploying enterprise AI, the question of whether Palantir’s hands-on model remains a differentiator or becomes a liability is a fair one to ask.

The Bigger Picture

What this week’s episode illustrates isn’t necessarily that Burry is right or wrong about Palantir specifically. It’s that the AI investment landscape is entering a more complex phase — one where the market is beginning to draw distinctions between infrastructure plays, model providers, and application layers, and debating which of those tiers captures the most durable value.

Anthropic’s valuation recently reached $380 billion, a figure that reflects investor conviction that the model layer is where the leverage lives. Palantir’s case rests on the idea that data infrastructure and operational trust — particularly in government — represent a moat that model providers cannot easily replicate.

Both arguments have merit. The risk for investors is that at current valuations, both stocks demand a level of confidence in the future that leaves little margin for disappointment.

As always, one social media post — even a deleted one — is not a thesis. But when Michael Burry posts, it’s worth understanding exactly what he’s saying and why the market reacted the way it did.